Logo

American Heart Association

  67
  0


Final ID:

Discussant: OPTIMA-AF trial

  • Patel, Manesh  ( DUKE MEDICAL CENTER , Durham , North Carolina , United States )
  • Author Disclosures:
    Manesh Patel: DO have relevant financial relationships ; Consultant:Bayer:Past (completed) ; Consultant:Janssen:Past (completed) ; Consultant:Esperon:Past (completed) ; Researcher:Idorsia:Active (exists now) ; Researcher:Regeneron:Active (exists now) ; Researcher:Bayer:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Dilemmas in Antithrombotic Therapy in AF Care Post Procedures

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Late-Breaking Science

More abstracts on this topic:
The Need for Ongoing Oral Anticoagulation in Patients with Clinical Stroke Risk Factors After Successful Catheter Ablation of Atrial Fibrillation: The OCEAN Randomized Trial

Verma Atul, Essebag Vidal, Champagne Jean, Hill Michael, Smith Eric, Wells George, Birnie David, Jiang Chenyang, Heidbuchel Hein, Hindricks Gerhard, Kirchhof Paulus, Healey Jeff, Sharma Mike, Ha Andrew

Short Dual Antithrombotic Therapy after PCI in Patients with Atrial Fibrillation: OPTIMA-AF trial

Sotomi Yohei, Kobayashi Ken, Ichibori Yasuhiro, Ishihara Takayuki, Hirooka Keiji, Suwa Satoru, Warisawa Takayuki, Naganuma Toru, Kikuchi Atsushi, Shutta Ryu, Okamoto Naotaka, Kozuma Ken, Tanabe Yasuhiro, Okamura Atsunori, Kashiwabara Kosuke, Hikoso Shungo, Sakata Yasushi, Higuchi Yoshiharu, Nakazawa Gaku, Morino Yoshihiro, Ando Kenji, Ako Junya, Tanabe Kengo, Muramatsu Takashi

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available